logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Malignant Neoplasm Of Prostate

    FiltersReset Filters
    12 results

    • choline c 11

      (Choline C-11)
      Mayo Clinic
      Usage: Choline C 11 Injection is indicated for PET imaging in patients with suspected prostate cancer recurrence, particularly when other imaging methods are inconclusive. It aids in identifying recurrence sites but does not replace histologic confirmation. Suspicions arise from elevated PSA levels following initial therapy.

    • gallium ga-68 psma-11

      (GALLIUM GA-68 GOZETOTIDE)
      UCSF Radiopharmaceutical Facility
      Usage: Gallium Ga 68 Gozeotide Injection is indicated for PET imaging of PSMA-positive lesions in men with prostate cancer, specifically for those with suspected metastasis who are candidates for initial therapy, and for those with suspected recurrence indicated by elevated serum PSA levels.

    • illuccix

      (Kit for the preparation of gallium Ga 68 gozetotide injection)
      Telix Pharmaceuticals (US) Inc.
      Usage: ILLUCCIX, after Ga 68 radiolabeling, is indicated for PET imaging of PSMA-positive lesions in men with prostate cancer: to assess suspected metastasis for initial therapy, evaluate recurrence due to elevated PSA, and to select candidates for lutetium Lu 177 PSMA-directed therapy.

    • leuprolide acetate

      (leuprolide acetate)
      UBI Pharma Inc.
      Usage: Leuprolide acetate injection is indicated for the palliative treatment of advanced prostatic cancer.

    • leuprolide acetate

      (Leuprolide Acetate)
      VGYAAN Pharmaceuticals LLC
      Usage: Leuprolide acetate injection is indicated for the palliative treatment of advanced prostatic cancer.

    • leuprolide acetate

      (Leuprolide Acetate)
      Sandoz Inc
      Usage: Leuprolide acetate injection is indicated for the palliative treatment of advanced prostatic cancer.

    • leuprolide acetate

      (leuprolide acetate)
      Amneal Pharmaceuticals LLC
      Usage: Leuprolide acetate injection is indicated for the palliative treatment of advanced prostatic cancer.

    • leuprolide acetate

      (Leuprolide Acetate)
      NorthStar RxLLC
      Usage: Leuprolide acetate injection is indicated for the palliative treatment of advanced prostatic cancer.

    • locametz

      (kit for the preparation of gallium Ga 68 gozetotide)
      Advanced Accelerator Applications USA, Inc
      Usage: LOCAMETZ, after radiolabeling with gallium-68, is used for PET imaging of PSMA-positive lesions in men with prostate cancer, aiding in the detection of metastasis, recurrence based on elevated PSA levels, and selection of patients for PSMA-directed therapy.

    • pluvicto

      (lutetium Lu 177 vipivotide tetraxetan)
      Advanced Accelerator Applications USA, Inc
      Usage: PLUVICTO is indicated for adult patients with PSMA-positive metastatic castration-resistant prostate cancer (mCRPC) who have previously received androgen receptor pathway inhibition and taxane-based chemotherapy.